NCT00030121View on ClinicalTrials.gov

Carperitide in Acute Respiratory Distress Syndrome (ARDS)

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1999

Conditions
Respiratory Distress Syndrome
Interventions
DRUG

recombinant human atrial natriuretic polypeptide

All Listed Sponsors
lead

Suntory Pharmaceutical

INDUSTRY

NCT00030121 - Carperitide in Acute Respiratory Distress Syndrome (ARDS) | Biotech Hunter | Biotech Hunter